Consumption value of health & its evolution over time James K. - - PowerPoint PPT Presentation

consumption value of health amp its
SMART_READER_LITE
LIVE PREVIEW

Consumption value of health & its evolution over time James K. - - PowerPoint PPT Presentation

Consumption value of health & its evolution over time James K. Hammitt Harvard ard Center er for Risk Analysi ysis Outline Conceptual issues Evidence (relevant, available) Reasonable assessment 2 Value per statistical case


slide-1
SLIDE 1

Consumption value of health & its evolution over time

James K. Hammitt

Harvard ard Center er for Risk Analysi ysis

slide-2
SLIDE 2

Outline

  • Conceptual issues
  • Evidence (relevant, available)
  • Reasonable assessment

2

slide-3
SLIDE 3

Value per statistical case

  • Individual’s rate of substitution between own:

― wealth ― probability of avoiding/preventing specified health outcome

  • within defined time period
  • Most research on small changes in probability of death

― Value per statistical life (VSL) ― Marginal rate of substitution ― Model can be applied to non-fatal health effects

3

slide-4
SLIDE 4

VSL = slope (local)

4

Indifference curve Wealth Survival probability ( = 1 - risk) 1

VSL x

slide-5
SLIDE 5

Standard model of VSL

  • maximize 𝐹𝑉 = 𝑡𝑣𝑏 + 1 − 𝑡 𝑣𝑒

― s = probability of surviving time period ― ua = utility conditional on surviving period ― ud = utility of leaving wealth as a bequest ― ua, ud are functions of

  • wealth
  • future conditions given survival

– life expectancy – health – earnings, expenses – other factors that influence wellbeing

  • future conditions given death

– number dependents – preferences for leaving wealth to others

5

slide-6
SLIDE 6

Standard model of VSL

  • 𝑊𝑇𝑀 = −

𝑒𝑥 𝑒𝑡 = 𝑣𝑏−𝑣𝑒 𝑡𝑣𝑏

′ + 1−𝑡 𝑣𝑒 ′ =

∆𝑣 𝐹𝑣′ = 𝑣𝑢𝑗𝑚𝑗𝑢𝑧 𝑤𝑏𝑚𝑣𝑓 𝑝𝑔 𝑡𝑣𝑠𝑤𝑗𝑤𝑏𝑚 𝐹 (𝑝𝑞𝑞𝑝𝑠𝑢𝑣𝑜𝑗𝑢𝑧 𝑑𝑝𝑡𝑢 𝑝𝑔 𝑡𝑞𝑓𝑜𝑒𝑗𝑜𝑕)

  • Assume

ua > ud survival preferred to death ua' > ud' ≥ 0 marginal utility of wealth larger given survival marginal utility of bequest non-negative ua", ud" ≤ 0 (weak) aversion to financial risk

  • Conclude

𝜖𝑊𝑇𝑀 𝜖𝑥 > 0 𝜖𝑊𝑇𝑀 𝜖𝑦 ⪋ 0?

6

― Increase in x (health, life expectancy):

  • Increases numerator
  • May increase denominator

― Increase in w:

  • Increases numerator
  • Decreases denominator
slide-7
SLIDE 7

What would constitute relevant evidence for evolution of value of health?

  • Value of health is ratio of

― Utility gain from better health (numerator) ― Expected opportunity cost of spending (denominator)

  • Value of health does not change autonomously
  • May change in response to changes in factors that affect

numerator and/or denominator

― To forecast change in value of health, must forecast changes in values of factors that influence it

7

t t t i i i

dv v v x w dt w t x t          

slide-8
SLIDE 8

What would constitute relevant evidence for evolution of value of health?

  • Numerator & denominator depend on multiple factors

that may change over time

― Wealth, real income

  • Increase value of health
  • Note: utility value of consumption depends on

– Available goods & services, which change over time – Risks to wealth & consumption – Risks to health that affect utility of consumption

― Effects of health, life expectancy, other factors?

  • For VSL, health & life expectancy increase numerator, may

increase denominator

  • Value of avoiding nonfatal health state

― Technology, social support decrease numerator, decrease value?

8

slide-9
SLIDE 9

Available evidence: empirical estimates

9

  • Revealed preference (compensating wage differentials)

― Cannot estimate wealth dependence directly

  • wage is dependent variable

― Compare VSL with income & other factors between samples

  • Meta-analysis, cross sections at different dates
  • Stated preference

― Estimate effects of income & individual characteristics on WTP within sample ― Compare VSL with income & other factors between samples

  • Wealth v. other factors

― Within-sample comparisons can isolate effect of wealth ― Between-sample comparisons include effects of other factors

  • Little research on

― effects of factors other than income (some on age) ― effect of income & other factors on value of nonfatal risk

slide-10
SLIDE 10

Empirical estimates (mostly US)

10

Referen rence ce Method hod Income

  • me elasticity

ticity Kniesner, Viscusi, & Ziliak 2010 Wage differential, quantile regression 1.2 – 2.2 (highest to lowest quintile) Viscusi 2015 Wage differential, meta-analysis 0.8 – 1.1 Viscusi & Masterman 2017 Wage differential, meta-analysis 0.5 (US) 1.1 (international) Corso, Hammitt, & Graham 2001 Stated preference, traffic risk 0.4 Hammitt & Haninger 2010 Stated preference, pesticides 0.1 Cameron & DeShazo 2003 Stated preference, multiple 0.7 Costa & Kahn 2004 Wage differential 1940-1980 v. GNI pc 1.5 – 1.7 Hammitt, Liu, & Liu 2017 Wage differential 1982-1997 Taiwan v. HH income, risk, workers 0.6 – 0.9

slide-11
SLIDE 11

In preparation

11

  • SP study in Chengdu, China, 2005 & 2016

― VSL increased 20x ($25,000 → $500,000) ― Household income increased 4x ($3,000 → $12,000)

  • Meta-analysis of VSL estimates in LMICs

― General population, data collected in last 20 years

  • 34 SP studies (17 countries)
  • 9 RP studies (8 countries)

― Regress VSL/GNI pc on GNI pc

  • SP: income elasticity ≈ 0.7
  • RP: income elasticity ≈ 0.1
slide-12
SLIDE 12

Stated preference

12

slide-13
SLIDE 13

Revealed preference

13

slide-14
SLIDE 14

A reasonable assessment?

14

  • Project change in value as (change in wealth) x

(response to wealth)

― Project change in wealth/income ― Use a central-value wealth elasticity of about 1

  • Conduct sensitivity analysis

― Could changes in factors other than wealth be important?

  • Be very humble